I'll give you mushrooms but that's it.
And as I mentioned, the scientific community sin;t in wholesale agreement on this.
"The development of rapid diagnostic tools are enabling better diagnoses/classifications and provide for a better understanding of DSD conditions, better genetic counseling, assessment of reproductive options and more precise outcome studies.
New genetic and genomic technologies are expanding our knowledge of the underlying mechanisms of DSDs and open novel clinical diagnostic strategies. At patient presentation, the current approach is to (a) search for additional phenotypic information, including urgent metabolic and endocrine testing and imaging studies; (b) rapidly identify the sex chromosome complement by karyotype analysis or FISH with X and Y probes and chromosome microarray, and (c) test for copy number variants in regions associated with known DSD genes. Gene sequencing, either of single candidate genes or a gene panel, based on information gleaned from previous phenotypic investigations, is often the last step of the diagnostic process.
Only limited numbers of the many identified genes involved in sex development are currently available for clinical testing. The current standard for genetic diagnosis is sequencing a small number of known DSD-causative genes chosen as likely candidates based on disease phenotype. Large numbers of patients do not receive a clinical molecular diagnosis using this narrow scope, and it is assumed that many DSD-causative genes remain to be identified.
An alternative diagnostic approach could use next-generation sequencing (whole exome or whole genome sequencing) as a first-line clinical test and lead to a rapid and definitive diagnosis in the majority of cases. However, this approach is faced with hurdles including long turn-around times, high costs, a lack of insurance approval or national healthcare system coverage and difficulties in the interpretation of the results, such as questions about reporting of nonrelated incidental findings or sequence variations which are significant but not recognized as such. These obstacles are likely to be overcome in the future, and next-generation sequencing is likely to become one of the first methods used for the diagnosis of DSD.
Currently, in instances in which a genetic diagnosis and the risk of recurrence are known, there is the possibility of prenatal diagnosis in subsequent pregnancies.
A review of human sex determination genetics has recently been published [
42]. The complexity of genetic regulation, even with advanced technology to identify mutations and copy number variations, is insufficient to explain the observed phenotypes. Genetics alone remains unable to explain the biological and psychological issues related to individuals with DSDs."
https://www.karger.com/Article/FullText/442975
However none of that changes the point I was actually making, which is the member I quoted conflating Sex and Gender.